resveratrol has been researched along with Lymphoma in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Alwan, AF; Hasan, ZYM; Jasim, AA; Obed, FAA | 1 |
| Frazzi, R; Guardi, M | 1 |
| Atadja, P; Buettner, R; Cermak, JM; Jove, R; Kirschbaum, M; Kujawski, M; Scuto, A | 1 |
| Frazzi, R; Tigano, M | 1 |
| Bhat, AA; Khan, OS; Krishnankutty, R; Mohammad, RM; Uddin, S | 1 |
| Athar, M; Back, JH; Bickers, DR; Kim, AL; Kopelovich, L | 1 |
| Guan, H; Hegde, VL; Hofseth, L; Nagarkatti, M; Nagarkatti, PS; Singh, NP; Singh, UP | 1 |
| Lehmann, L; Metzler, M; Schmitt, E; Stopper, H | 1 |
4 review(s) available for resveratrol and Lymphoma
| Article | Year |
|---|---|
Cellular and Molecular Targets of Resveratrol on Lymphoma and Leukemia Cells.
Topics: Anticarcinogenic Agents; Humans; Leukemia; Lymphoma; Resveratrol; Stilbenes | 2017 |
The multiple mechanisms of cell death triggered by resveratrol in lymphoma and leukemia.
Topics: Angiogenesis Inhibitors; Animals; Apoptosis; Biomarkers, Tumor; Cell Line, Tumor; Humans; Leukemia; Lymphoma; Models, Biological; Resveratrol; Stilbenes | 2014 |
Therapeutic Potential of Resveratrol in Lymphoid Malignancies.
Topics: Anticarcinogenic Agents; Antineoplastic Agents, Phytogenic; Humans; Lymphoma; Multiple Myeloma; Resveratrol; Stilbenes | 2016 |
Multiple molecular targets of resveratrol: Anti-carcinogenic mechanisms.
Topics: Anticarcinogenic Agents; Breast Neoplasms; Cathepsins; Cell Cycle; Cell Division; Female; Humans; Inflammation; Leukemia; Lymphoma; Male; Neoplasms; Prostatic Neoplasms; Resveratrol; Safety; Stilbenes; Transcription Factors | 2009 |
4 other study(ies) available for resveratrol and Lymphoma
| Article | Year |
|---|---|
Topics: Cytokines; Humans; Interleukin-10; Iraq; Lymphocytes; Lymphoma; Resveratrol; Tumor Necrosis Factor-alpha; Vitis | 2022 |
SIRT1 activation enhances HDAC inhibition-mediated upregulation of GADD45G by repressing the binding of NF-κB/STAT3 complex to its promoter in malignant lymphoid cells.
Topics: Acetylation; Apoptosis; Cell Line, Tumor; Enzyme Inhibitors; GADD45 Proteins; Heterocyclic Compounds, 4 or More Rings; Histone Deacetylase Inhibitors; Histone Deacetylases; Histones; Humans; Hydroxamic Acids; Indoles; Intracellular Signaling Peptides and Proteins; Lymphoma; NF-kappa B; Panobinostat; Phosphorylation; Promoter Regions, Genetic; Protein Binding; Proto-Oncogene Proteins c-myc; Resveratrol; RNA Interference; RNA, Small Interfering; Sirtuin 1; STAT3 Transcription Factor; Stilbenes; Up-Regulation | 2013 |
Resveratrol (trans-3,5,4'-trihydroxystilbene) suppresses EL4 tumor growth by induction of apoptosis involving reciprocal regulation of SIRT1 and NF-κB.
Topics: Animals; Anticarcinogenic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Line, Tumor; Fas Ligand Protein; fas Receptor; Gene Expression Regulation, Neoplastic; Lymphoma; Mice; Mice, Inbred NOD; Mice, SCID; NF-kappa B; Receptors, Aryl Hydrocarbon; Resveratrol; Sirtuin 1; Stilbenes | 2011 |
Hormonal and genotoxic activity of resveratrol.
Topics: Animals; Breast Neoplasms; Cell Cycle; Cell Division; Cell Survival; CHO Cells; Cricetinae; Dose-Response Relationship, Drug; Estrogen Receptor alpha; Fluorescein-5-isothiocyanate; Humans; Kinetochores; Lymphoma; Metaphase; Mice; Micronucleus Tests; Molecular Structure; Protein Binding; Receptors, Estrogen; Resveratrol; Stilbenes; Time Factors; Tubulin; Tumor Cells, Cultured | 2002 |